These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9332696)

  • 1. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines.
    Oesch-Bartlomowicz B; Arens HJ; Richter B; Hengstler JG; Oesch F
    Arch Toxicol; 1997; 71(10):601-11. PubMed ID: 9332696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of the mutagenicity of arylamines by protein kinases and phosphatases: II. Lack of response of rat liver N-acetyl transferases to phosphorylation modulators.
    Padma PR; Oesch-Bartlomowicz B; Hengstler JG; Oesch F
    Arch Toxicol; 1997; 71(10):655-9. PubMed ID: 9332704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay.
    Inami K; Okazawa M; Mochizuki M
    Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells.
    Rodrigues AS; Silva ID; Caria MH; Laires A; Chaveca T; Glatt HR; Rueff J
    Mutat Res; 1994 Dec; 341(2):93-100. PubMed ID: 7527492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphatase inhibitor okadaic acid stimulates the TSH-induced G1-S phase transition in thyroid cells.
    Lazzereschi D; Coppa A; Minicione G; Lavitrano M; Fragomele F; Colletta G
    Exp Cell Res; 1997 Aug; 234(2):425-33. PubMed ID: 9260913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of aromatic amines to mutagens by various animal species including man.
    Phillipson CE; Ioannides C
    Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice.
    Møller ME; Glowinski IB; Thorgeirsson SS
    Carcinogenesis; 1984 Jun; 5(6):797-804. PubMed ID: 6722987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
    Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
    Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of protein phosphatases in the expression of inducible nitric oxide synthase in the rat hepatocyte.
    Taylor BS; Liu S; Villavicencio RT; Ganster RW; Geller DA
    Hepatology; 1999 Apr; 29(4):1199-207. PubMed ID: 10094965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of conjugation reactions on the mutagenicity of aromatic amines.
    Hongslo J; Haug LT; Wirth PJ; Møller M; Dybing E; Thorgeirsson SS
    Mutat Res; 1983 Feb; 107(2):239-47. PubMed ID: 6346076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
    Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
    Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenic activation of aromatic amines by a human hepatoma cell (Hep G2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities.
    Duverger-van Bogaert M; Dierickx PJ; Crutzen MC
    Mutat Res; 1995 Dec; 335(3):219-27. PubMed ID: 8524336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of okadaic acid, calyculin A, and PDBu on state of phosphorylation of rat renal Na+-K+-ATPase.
    Li D; Cheng SX; Fisone G; Caplan MJ; Ohtomo Y; Aperia A
    Am J Physiol; 1998 Dec; 275(6):F863-9. PubMed ID: 9843902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines.
    Yueh MF; Nguyen N; Famourzadeh M; Strassburg CP; Oda Y; Guengerich FP; Tukey RH
    Carcinogenesis; 2001 Jun; 22(6):943-50. PubMed ID: 11375903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of enzymes involved in activation of 2-aminoanthracene varies with the metabolic system applied.
    Veres Z; Török G; Tóth E; Vereczkey L; Jemnitz K
    Mutat Res; 2005 Sep; 586(1):18-27. PubMed ID: 16006184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
    Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
    Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the protein phosphatase inhibitor okadaic acid on FSH-induced granulosa cell steroidogenesis.
    González Reyes J; Santana P; González Robaina I; Cabrera Oliva J; Estévez F; Hernández I; López Blanco F; Quintana Aguiar J; Fanjul LF; Ruiz de Galarreta CM
    J Endocrinol; 1997 Jan; 152(1):131-9. PubMed ID: 9014848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.